Covered recipient · General Payments record
KELLY P NORMAN
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$2,855.10
- Reported across 161 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $381.11 | 17 |
| Education | $13.35 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $159.99 | 10 |
| Axonics Modulation Technologies, Inc. | $86.15 | 1 |
| Astellas Pharma US Inc | $37.84 | 2 |
| MILLICENT US INC | $36.74 | 2 |
| Medtronic, Inc. | $29.64 | 1 |
| Exeltis, USA Inc. | $23.01 | 1 |
| ABBVIE INC. | $21.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.09 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105132901 | CMS |
| Astellas Pharma US Inc | $16.97 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139323210 | CMS |
| Astellas Pharma US Inc | $20.87 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139340880 | CMS |
| Axonics, Inc. | $86.15 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142362950 | CMS |
| Exeltis, USA Inc. | $23.01 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150000862 | CMS |
| Medtronic, Inc. | $29.64 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119265338 | CMS |
| MILLICENT US INC | $23.39 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150910450 | CMS |
| MILLICENT US INC | $13.35 | 11/06/2024 | Education | Undisputed | 01/23/2026 | 1150910452 | CMS |
| Novo Nordisk Inc | $7.33 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096785841 | CMS |
| Novo Nordisk Inc | $22.24 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097518684 | CMS |
| Novo Nordisk Inc | $20.37 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096822140 | CMS |
| Novo Nordisk Inc | $13.75 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097742259 | CMS |
| Novo Nordisk Inc | $21.30 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097620193 | CMS |
| Novo Nordisk Inc | $17.84 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096621644 | CMS |
| Novo Nordisk Inc | $3.60 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096603299 | CMS |
| Novo Nordisk Inc | $4.06 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096913748 | CMS |
| Novo Nordisk Inc | $23.81 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096919124 | CMS |
| Novo Nordisk Inc | $25.69 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097614190 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.